These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 26526751

  • 1. Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.
    Armando M, Pontillo M, De Crescenzo F, Mazzone L, Monducci E, Lo Cascio N, Santonastaso O, Pucciarini ML, Vicari S, Schimmelmann BG, Schultze-Lutter F.
    Schizophr Res; 2015 Dec; 169(1-3):186-192. PubMed ID: 26526751
    [Abstract] [Full Text] [Related]

  • 2. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C, Toffel E, Schmidt SJ, Eliez S, Armando M, Solida-Tozzi A, Schultze-Lutter F, Debbané M.
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [Abstract] [Full Text] [Related]

  • 3. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N, Saba R, Hauser M, Vernal DL, Al-Jadiri A, Borenstein Y, Sheridan EM, Kishimoto T, Armando M, Vicari S, Fiori Nastro P, Girardi P, Gebhardt E, Kane JM, Auther A, Carrión RE, Cornblatt BA, Schimmelmann BG, Schultze-Lutter F, Correll CU.
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [Abstract] [Full Text] [Related]

  • 4. Transition and remission in adolescents at ultra-high risk for psychosis.
    Ziermans TB, Schothorst PF, Sprong M, van Engeland H.
    Schizophr Res; 2011 Mar; 126(1-3):58-64. PubMed ID: 21095104
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cognitive functioning in at-risk mental states for psychosis and 2-year clinical outcome.
    Simon AE, Grädel M, Cattapan-Ludewig K, Gruber K, Ballinari P, Roth B, Umbricht D.
    Schizophr Res; 2012 Dec; 142(1-3):108-15. PubMed ID: 23025995
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, Klaassen R, de Haan L, van Amelsvoort T, Linszen DH.
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J.
    Aust N Z J Psychiatry; 2005 Apr; 39(11-12):964-71. PubMed ID: 16343296
    [Abstract] [Full Text] [Related]

  • 12. Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis.
    Liu CC, Hua MS, Hwang TJ, Chiu CY, Liu CM, Hsieh MH, Chien YL, Lin YT, Hwu HG.
    Schizophr Res; 2015 May; 164(1-3):40-6. PubMed ID: 25802138
    [Abstract] [Full Text] [Related]

  • 13. Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.
    Lin A, Wood SJ, Nelson B, Brewer WJ, Spiliotacopoulos D, Bruxner A, Broussard C, Pantelis C, Yung AR.
    Schizophr Res; 2011 Oct; 132(1):1-7. PubMed ID: 21763109
    [Abstract] [Full Text] [Related]

  • 14. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
    de Wit S, Schothorst PF, Oranje B, Ziermans TB, Durston S, Kahn RS.
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
    [Abstract] [Full Text] [Related]

  • 15. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S, Kollias C, Stefanis NC, Kontaxakis V.
    Psychiatriki; 2015 Jun; 26(1):45-54. PubMed ID: 25880383
    [Abstract] [Full Text] [Related]

  • 16. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M, Kim KR, Song YY, Baek S, Lee E, An SK.
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [Abstract] [Full Text] [Related]

  • 17. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.
    Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, Birchwood M, Patterson P, Juckel G, Heinz A, Morrison A, Lewis S, von Reventlow HG, Klosterkötter J.
    Arch Gen Psychiatry; 2010 Mar; 67(3):241-51. PubMed ID: 20194824
    [Abstract] [Full Text] [Related]

  • 18. High remission rates from an initial ultra-high risk state for psychosis.
    Simon AE, Umbricht D.
    Schizophr Res; 2010 Feb; 116(2-3):168-72. PubMed ID: 19854621
    [Abstract] [Full Text] [Related]

  • 19. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?
    Nelson B, Yuen K, Yung AR.
    Schizophr Res; 2011 Jan; 125(1):62-8. PubMed ID: 21074975
    [Abstract] [Full Text] [Related]

  • 20. General intellectual functioning as a buffer against theory-of-mind deficits in individuals at ultra-high risk for psychosis.
    Hur JW, Byun MS, Shin NY, Shin YS, Kim SN, Jang JH, Kwon JS.
    Schizophr Res; 2013 Sep; 149(1-3):83-7. PubMed ID: 23810120
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.